2022-01-17T17:57:40+00:00

MEI
Pharma

PIPE Transaction
Follow-on Offering
Common Stock

$52,325,000

Financial Advisor
December 2021

2022-01-17T18:11:46+00:00


aTyr Pharma Inc.

Follow-On Offering
Common Stock
 

$86,250,000

Lead Manager
September 2021

2022-01-18T14:13:53+00:00

 
Perfect Moment

Private
Placement
 

$6,000,000

Exclusive Placement Agent
May 2021

2022-01-15T17:34:02+00:00


iCAD Inc.

Follow-On Offering
Common Stock
.

$25,000,000

Co-Manager
March 2021

2022-01-18T14:14:20+00:00

Aerwave
Medical

Series A
Offering
 

$4,000,000

Exclusive Placement Agent
February 2021

2022-01-15T17:24:47+00:00


Evoke Pharma

Follow-On Offering
Common Stock
.

$14,375,000

Sole Book-Runner
January 2021

2022-01-15T17:05:00+00:00


Affimed

Follow-On Offering
Common Stock
.

$115,00,000

Co-Manager
January 2021

2022-01-18T14:14:47+00:00

 
PD Theranostics

Series A Offering
 
 

$3,000,000

Exclusive Placement Agent
August 2020

2022-01-18T14:15:14+00:00

Voltron
Therapeutics

Series A
Preferred Offering
 

$3,500,000

Exclusive Placement Agent
June 2020

2022-01-15T18:04:35+00:00


Affimed

Follow-On Offering
Common Stock
.

$34,500,000

Co-Manager
November 2019

2022-01-18T14:15:53+00:00

Algorithm
Sciences

Series A
Offering
 

$3,500,000

Exclusive Placement Agent
December 2018

2022-01-15T19:23:03+00:00

MEI
Pharma

PIPE Transaction
Common Stock and
Warrants

$75,000,000

Co-Placement Agent
May 2018

2022-01-15T19:22:31+00:00

Sesen
Bio

Registered Direct
Common Stock and
Warrants

$10,000,000

Exclusive Placement Agent
March 2018

2022-01-15T19:18:09+00:00


AIT Therapeutics

PIPE Transaction
Warrants
.

$9,820,154.54

Exclusive Placement Agent
February 2018

2022-01-15T19:23:26+00:00


Affimed

Follow-On Offering
Common Stock
 

$23,000,000

Financial Advisor
February 2018

2022-01-15T19:28:02+00:00

Cytori
Therapeutics

Rights Offering
Convertible Preferred
Stock and Warrants

$10,000,000

Financial Advisor
November 2017

2022-01-15T19:28:54+00:00

Onconova
Therapeutics

Registered Direct
Common Stock
 

$1,380,000

Sole Placement Agent
November 2017

2022-01-16T20:40:18+00:00


US Gold Corporation

Confidentially Marketed Public Offering
Common Stock

$2,500,000

Sole Book Runner
October 2017

2022-01-16T21:07:38+00:00

Spherix, Inc.

Follow-On Offering
 
 

$2,500,000

Sole Book Runner
July 2017

2022-01-16T21:09:46+00:00

Repros
Therapeutics

Confidentially Marketed
Public Offering
Common Stock and Warrants

$3,000,000

Sole Book-Runner
May 2017

2022-01-16T21:10:41+00:00

Onconova
Therapeutics

Confidentially Marketed
Public Offering
Common Stock

$5,963,517

Sole Book Runner
April 2017

2022-01-16T21:11:01+00:00


BioSig Technologies

PIPE Transaction
Common Stocks
& Warrants

$4,349,954

Exclusive Placement Agent
March 2017

2022-01-17T17:41:37+00:00


AIT Therapeutics

PIPE Transaction,
Common Stock
and Warrants

$10,200,000

Placement Agent
March 2017

2022-01-16T21:12:29+00:00

Therapix
Biosciences

Initial Public Offering
Common Stock
 

$13,800,000

Sole Book Runner
March 2017

2022-01-16T21:12:46+00:00

Gemphire

PIPE Transaction
Common Stock & Warrants
 

$12,500,000

Co-Manager
March 2017

2022-01-16T21:14:34+00:00


Function (x), Inc.

Follow-On Offering
Common Stock
 

$5,000,000

Joint Book Runner
February 2017

2022-01-17T17:41:21+00:00


Medovex Corporation

PIPE Transaction
Common Stock & Warrants
 

$3,022,000

Exclusive Placement Agent
February 2017

2022-01-17T17:41:00+00:00

Towersteam Corporation

Confidentially Marketed
Public Offering
Common Stock

$4,000,000

Sole Book Runner
November 2016

2022-01-17T17:40:16+00:00

US Gold Corporation

Private Placement
Common Stock
 

$12,000,000

Exclusive Placement Agent
October 2016

2022-01-17T17:40:43+00:00


FTE Networks, Inc.

PIPE Transaction
Common Stock
& Warrants

$2,990,000

Exclusive Placement Agent
October 2016

2022-01-17T17:39:47+00:00


Spherix, Inc.

Confidentially Marketed
Public Offering
Common Stock

$2,500,000

Sole Book Runner
August 2016

2022-01-17T00:39:13+00:00


ImmunoCellular

Follow-On Offering
Common Stocks
& Warrants

$7,400,000

Lead Manager
August 2016

2022-01-17T01:05:30+00:00


Gemphire

Initial Public Offering
Common Stock
 

$30,000,000

Co-Manager
August 2016

2022-01-17T01:05:50+00:00


PhaseRx

Initial Public
Offering
Common Stock

$18,500,000

Book Runner
May 2016

2022-01-17T17:35:26+00:00

Medovex
Corporation

PIPE Transaction
Common Stock
& Warrants

$1,398,033

Placement Agent
April 2016